Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells

9Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Regular use of aspirin can reduce cancer incidence, recurrence, metastasis and cancer-related mortality. Aspirin suppresses proliferation and induces apoptosis and autophagy in colorectal cancer cells, but the precise mechanism is not clear. In this study, we demonstrated that aspirin induced autophagosome formation in colorectal cancer cells, but autophagic degradation was blocked through aspirin-mediated Beclin 1 acetylation. Blocked autophagic degradation weakened aspirin-induced cell death. Collectively, our findings indicate the dual roles of aspirin on autophagy, and demonstrate a new mechanism by which Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells.

Cite

CITATION STYLE

APA

Sun, T., Ming, L., Yan, Y., Zhang, Y., & Xue, H. (2017). Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells. Oncotarget, 8(43), 74781–74790. https://doi.org/10.18632/oncotarget.20367

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free